This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mehrotra, S. Articles by Mukherji, B. Search for Related Content PubMed PubMed Citation Articles by Mehrotra, S. Articles by Mukherji, B.

Regulation of Melanoma Epitope-specific Cytolytic T Lymphocyte Response by Immature and Activated Dendritic Cells, in Vitro¹

Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut 06030 [S. M., R. S., R. Z., N. G. C., D. I. D., B. M.], and Department of Surgery, UCLA Medical Center, Los Angeles, California 90095 [L. H. B., J. S. E.]

Dendritic cell (DC)-based immunization in cancer has proven to be a promising approach. However, just as DCs are crucial accessory cells in generating immune responses, they also seem to participate in tolerance induction, especially against peripheral "self" antigens. The bulk of the evidence that DCs present peripheral self antigens to induce tolerance has, however, come mostly from studies in transgenic animal models. A tolerogenic function of DCs for peripheral self antigens in a human model has not been critically examined. In this study using the Melan-A/MART-1_27–35 peptide as a model for self but melanoma-associated antigen–against which human hosts often harbor CD8⁺ CTL precursors with high frequencies–we confirm that although immature dendritic cells (iDCs) are inefficient antigen presenting cells (APCs), fully activated DCs efficiently activate melanoma epitope-specific CD8⁺ CTL precursors, in vitro. We, however, show that in a direct epitope presentation schema, iDCs neither delete nor anergize epitope-specific CD8⁺ T cells in primary or secondary stimulation. Interestingly, iDCs and activated DCs can delete a large fraction of the epitope-specific CTLs on tertiary stimulation. The deletion is induced in an epitope-specific manner and through apoptosis. These observations, therefore, have implications on the DC-based cancer vaccine designs and are relevant in the inquiry into the role of DCs on tolerance induction.

This article has been cited by other articles:

				S. Mehrotra, A. Chhabra, U. Hegde, N. G. Chakraborty, and B. Mukherji Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death J. Leukoc. Biol., February 1, 2007; 81(2): 539 - 547. [Abstract] [Full Text] [PDF]

				S. Chattopadhyay, S. Mehrotra, A. Chhabra, U. Hegde, B. Mukherji, and N. G. Chakraborty Effect of CD4+CD25+ and CD4+CD25- T Regulatory Cells on the Generation of Cytolytic T Cell Response to a Self but Human Tumor-Associated Epitope In Vitro J. Immunol., January 15, 2006; 176(2): 984 - 990. [Abstract] [Full Text] [PDF]

				Y. Wu, T. Wan, X. Zhou, B. Wang, F. Yang, N. Li, G. Chen, S. Dai, S. Liu, M. Zhang, et al. Hsp70-Like Protein 1 Fusion Protein Enhances Induction of Carcinoembryonic Antigen-Specific CD8+ CTL Response by Dendritic Cell Vaccine Cancer Res., June 1, 2005; 65(11): 4947 - 4954. [Abstract] [Full Text] [PDF]

				S. Mehrotra, A. Chhabra, S. Chattopadhyay, D. I. Dorsky, N. G. Chakraborty, and B. Mukherji Rescuing Melanoma Epitope-Specific Cytolytic T Lymphocytes from Activation-Induced Cell Death, by SP600125, an Inhibitor of JNK: Implications in Cancer Immunotherapy J. Immunol., November 15, 2004; 173(10): 6017 - 6024. [Abstract] [Full Text] [PDF]